-
1
-
-
0029780711
-
Molecular analysis of the granulocyte colony-stimulating factor receptor
-
Avalos B.R. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood. 88:1996;761-777
-
(1996)
Blood
, vol.88
, pp. 761-777
-
-
Avalos, B.R.1
-
2
-
-
0027494821
-
Signal transduction by the high-affinity GM-CSF receptor: Two distinct cytoplasmic regions of the common β subunit responsible for different signaling
-
Sato N., Sakamaki K., Terada N., Arai K., Miyajima A. Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common β subunit responsible for different signaling. EMBO J. 12:1993;4181-4189
-
(1993)
EMBO J.
, vol.12
, pp. 4181-4189
-
-
Sato, N.1
Sakamaki, K.2
Terada, N.3
Arai, K.4
Miyajima, A.5
-
3
-
-
0028053132
-
Proliferative but not nonproliferative responses to granulocyte-colony stimulating factor are associated with rapid activation of the p21ras/MAP kinase signalling pathway
-
Bashey A., Healy L., Marshall C.J. Proliferative but not nonproliferative responses to granulocyte-colony stimulating factor are associated with rapid activation of the p21ras/MAP kinase signalling pathway. Blood. 83:1994;949-957
-
(1994)
Blood
, vol.83
, pp. 949-957
-
-
Bashey, A.1
Healy, L.2
Marshall, C.J.3
-
4
-
-
0034847034
-
Modulation of MEK activity during G-CSF signaling alters proliferative versus differentiative balancing
-
Baumann M.A., Paul C.C., Lemley-Gillespie S., Oyster M., Gomez-Cambronero J. Modulation of MEK activity during G-CSF signaling alters proliferative versus differentiative balancing. Am. J. Hematol. 68:2001;99-105
-
(2001)
Am. J. Hematol.
, vol.68
, pp. 99-105
-
-
Baumann, M.A.1
Paul, C.C.2
Lemley-Gillespie, S.3
Oyster, M.4
Gomez-Cambronero, J.5
-
5
-
-
0035884996
-
Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines
-
Pathak M.K., Yi T. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. J. Immunol. 167:2001;3391-3397
-
(2001)
J. Immunol.
, vol.167
, pp. 3391-3397
-
-
Pathak, M.K.1
Yi, T.2
-
6
-
-
0034546849
-
A human cell line that differentiates to all myeloid lineages and expresses neutrophil secondary granule genes
-
Paul C.C., Aly E.-S., Lehman J.A., Page S.M., Gomez-Cambronero J., Ackerman S.J., et al. A human cell line that differentiates to all myeloid lineages and expresses neutrophil secondary granule genes. Exp. Hematol. 28:2000;1373-1380
-
(2000)
Exp. Hematol.
, vol.28
, pp. 1373-1380
-
-
Paul, C.C.1
Aly, E.-S.2
Lehman, J.A.3
Page, S.M.4
Gomez-Cambronero, J.5
Ackerman, S.J.6
-
7
-
-
0346996709
-
Granulocyte-macrophage colony-stimulating factor is a chemoattractant cytokine for human neutrophils: Involvement of the ribosomal p70S6 kinase signaling pathway
-
Gomez-Cambronero J., Horn J., Paul C.C., Baumann M.A. Granulocyte-macrophage colony-stimulating factor is a chemoattractant cytokine for human neutrophils: involvement of the ribosomal p70S6 kinase signaling pathway. J. Immunol. 171:2003;6846-6855
-
(2003)
J. Immunol.
, vol.171
, pp. 6846-6855
-
-
Gomez-Cambronero, J.1
Horn, J.2
Paul, C.C.3
Baumann, M.A.4
-
8
-
-
0029666255
-
S6 kinase p90rsk in GM-CSF-stimulated proliferative and mature hemopoietic cells
-
Joseph D., Paul C.C., Baumann M.A., Gomez-Cambronero J. S6 kinase p90rsk in GM-CSF-stimulated proliferative and mature hemopoietic cells. J. Biol. Chem. 271:1996;13088-13093
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 13088-13093
-
-
Joseph, D.1
Paul, C.C.2
Baumann, M.A.3
Gomez-Cambronero, J.4
-
9
-
-
0034677544
-
The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP
-
Pettiford S.M., Herbst R. The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP. Oncogene. 19:2000;858-869
-
(2000)
Oncogene
, vol.19
, pp. 858-869
-
-
Pettiford, S.M.1
Herbst, R.2
-
10
-
-
0033947111
-
The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor
-
Ward A.C., Oomen S.P.M.A., Smith L., Gits J., van Leeuwen D., Soede-Bobok A.A., et al. The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor. Leukemia. 14:2000;1284-1291
-
(2000)
Leukemia
, vol.14
, pp. 1284-1291
-
-
Ward, A.C.1
Oomen, S.P.M.A.2
Smith, L.3
Gits, J.4
Van Leeuwen, D.5
Soede-Bobok, A.A.6
-
11
-
-
0030838839
-
Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival
-
Seymour J.F., Lieschke G.J., Grail D., Quilici C., Hodgson G., Dunn A.R. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Blood. 90:1997;3037-3049
-
(1997)
Blood
, vol.90
, pp. 3037-3049
-
-
Seymour, J.F.1
Lieschke, G.J.2
Grail, D.3
Quilici, C.4
Hodgson, G.5
Dunn, A.R.6
-
12
-
-
0031047432
-
Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice
-
Tapley P., Shevde N.K., Schweitzer P.A., Gallina M., Christianson S.W., Lin I.L., et al. Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice. Exp. Hematol. 25:1997;122-131
-
(1997)
Exp. Hematol.
, vol.25
, pp. 122-131
-
-
Tapley, P.1
Shevde, N.K.2
Schweitzer, P.A.3
Gallina, M.4
Christianson, S.W.5
Lin, I.L.6
-
13
-
-
0035575765
-
The carboxyl terminus of the granulocyte colony stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression or stat activation
-
Dong F., Qiu Y., Yi T., Touw I.P., Larner A.C. The carboxyl terminus of the granulocyte colony stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression or stat activation. J. Immunol. 167:2001;6447-6452
-
(2001)
J. Immunol.
, vol.167
, pp. 6447-6452
-
-
Dong, F.1
Qiu, Y.2
Yi, T.3
Touw, I.P.4
Larner, A.C.5
|